EE371 Disease Management Costs for Patients With Intermediate-High or High-Risk Renal Cell Carcinoma (RCC) Following Nephrectomy
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.617
https://www.valueinhealthjournal.com/article/S1098-3015(22)02821-2/fulltext
Section Title :
Section Order :
10153
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02821-2&doi=10.1016/j.jval.2022.09.617